OncoLens QI Project Helps Improve Biomarker Testing Rates for Eligible Patients at Cancer Programs
The cancer programs included an NCI center, a regional IDN and a community cancer center. The life science industry sponsored program facilitated the assessment of current practices and the derivation of insights into local barriers to testing. The program subsequently addressed these barriers resulting in the overall improvement of NGS testing and targeted therapies in solid tumors possessing a rare gene fusion.
